NEU neuren pharmaceuticals limited

Acadia, page-1257

  1. 1,647 Posts.
    lightbulb Created with Sketch. 377
    Acadia's Q4 results presentation will be interesting. As most are aware Catherine Adams flagged 2025 as the first year for $1b in sales.
    Full year (2025CY) guidance will be provided in the Q4 results presentation, how much revenue is attributed to Daybue will be the driver for NEU analyst updates rather than the actual Q4 number. With Catherines' comments at the JP Morgan conference being bullish (return to growth, 30% increase in sales force) combined with other regions coming on board, i am expecting a good number being forecast.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$17.55
Change
0.540(3.17%)
Mkt cap ! $2.211B
Open High Low Value Volume
$17.48 $18.44 $17.40 $16.43M 922.3K

Buyers (Bids)

No. Vol. Price($)
4 2624 $17.53
 

Sellers (Offers)

Price($) Vol. No.
$17.70 1000 1
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.